Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Fundamental diagnostic hematology; the bleeding and clotting disorders
  • Published Date:
    1992
Filetype[PDF-2.76 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Fundamental diagnostic hematology; the bleeding and clotting disorders
    Personal Author:
    Evatt, Bruce L.
    Corporate Authors:
    Centers for Disease Control (U.S.)
    Published Date:
    2nd ed., 1992
    Description:
    Rev. ed. of: Fundamental diagnostic laboratory hematology / Bruce L. Evatt ... [et al.]. 1985.
    File Type:
    Filetype[PDF - 2.81 MB]
  2. Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System
    Personal Author:
    KULKARNI, R.; PRESLEY, R. J.; LUSHER, J. M.; SHAPIRO, A. D.; GILL, J. C.; MANCO-JOHNSON, M.; KOERPER, M. A.; ABSHIRE, T. C.; DIMICHELE, D.; HOOTS, W. K.; MATHEW, P.; NUGENT, D. J.; GERAGHTY, S.; EVATT, B. L.; SOUCIE, J. M.;
    Published Date:
    Nov 04 2016
    Source:
    Haemophilia. 23(2):207-214.
    Description:
    AimTo describe the prevalence and complications in babies ≤2 years with haemophilia.MethodsWe used a standardized collection tool to obtain consented data on eligible babies aged ≤2 years with haemophilia enrolled in the Centers for Disease Contr...
    File Type:
    Filetype[PDF - 273.94 KB]
  3. Meeting the Emerging Public Health Needs of Persons With Blood Disorders
    Personal Author:
    Parker, Christopher S.; Tsai, James; Siddiqi, Azfar-e-Alam; Atrash, Hani K.; Richardson, Lisa C.;
    Published Date:
    Sep 19 2014
    Source:
    Am J Prev Med. 47(5):658-663.
    Description:
    In its decades-long history, the Division of Blood Disorders (DBD) at CDC has evolved from a patient-focused, services-supporting entity at inception, to one of the world leaders in the practice of public health to improve the lives of people at risk...
    File Type:
    Filetype[PDF - 115.69 KB]
  4. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay
    Personal Author:
    Boylan, Brian; Rice, Anne S.; Dunn, Amy L.; Tarantino, Michael D.; Brettler, Doreen B.; Barrett, John C.; Miller, Connie H.;
    Corporate Authors:
    Hemophilia Inhibitor Research Study Investigators
    Published Date:
    Dec 11 2014
    Source:
    J Thromb Haemost. 13(1):47-53.
    Description:
    BackgroundThe development of neutralizing antibodies, referred to as inhibitors, against factor VIII (FVIII) is a major complication associated with FVIII infusion therapy for the treatment of hemophilia A (HA). Previous studies have shown that a sub...
    File Type:
    Filetype[PDF - 417.41 KB]
  5. Evaluation of CDC’s Hemophilia Surveillance Program — Universal Data Collection (1998–2011) and Community Counts (2011–2019), United States
    Personal Author:
    Schieve, Laura A.; Byams, Vanessa R.; Dupervil, Brandi; Oakley, Meredith A.; Miller, Connie H.; Soucie, J. Michael; Abe, Karon; Bean, Christopher J.; Hooper, W. Craig;
    Corporate Authors:
    National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Division of Blood Disorders.
    Published Date:
    September 4, 2020
    Series:
    MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries ; v. 69, SS-5
    Description:
    Problem/Condition: Hemophilia is an X-linked genetic disorder that primarily affects males and results in deficiencies in blood-clotting proteins. Hemophilia A is a deficiency in factor VIII, and hemophilia B is a deficiency in factor IX. Approximate...
    File Type:
    Filetype[PDF - 403.37 KB]